[Our experience with the 131-I treatment of thyrotoxicosis].
The authors analyze 100 patients, with thyrotoxicosis, 84 females and 16 males, treated with 131J. The enlargement of the thyroid gland was II degree in 57 per cent and III degree in 34 per cent, and I and II - for the rest of the cases. In 77 per cent the body weight of the patients was below the norm. Exophthalmos was observed in 48 per cent. As a result of treatment an involution of a series of pathological symptoms developed- tachycardia, ECG changes, exophthalmos, degree enlargement of the thyroid gland, blood indicies, weight, capacity for work. Euthyroidism was established in 86 per cent, partial remission in 12 per cent and hypothroidism - in 2 per cent, when followed up during an interval of 2-13 years. No genetic or blastomogenic changes were observed. Observations is recommended in the later periods after the treatment.
D000328:Adult; D000553:Ambulatory Care; D001835:Body Weight / Q000187:drug effects; D002031:Bulgaria; D002784:Cholesterol / Q000097:blood; D002908:Chronic Disease; D004562:Electrocardiography; D005094:Exophthalmos / Q000188:drug therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy*; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D008297:Male
D007457:Iodine Radioisotopes; D002784:Cholesterol
Nashiiat opit pri lechenieto na tireotoksikozata s 131J